Doctor and Patient

The Institute for Patient Access is a physician-led policy research organization dedicated to maintaining the primacy of the physician-patient relationship in the provision of quality health care.

POLICY TOPICS

Biologics
Cardiovascular
Co-Pay Accumulator Adjustment Programs
Cost Sharing
Cost Value
Cystic Fibrosis
Diabetes
Gout
Hepatitis
ICER
Infant
Informed RX
Innovation
Integrated Care
Neurological
Non-Medical Switching
Oncology
Pain
Pharmacovigilance
Prior Authorization
Rare Disease
Regulatory Issues
Respiratory
Step Therapy
Telehealth
Vision

For Some, Step Therapy Is a Matter of Death or Life

April 20, 2021

I had been experiencing chest pain for a while. It was robbing me of joy – and it was often embarrassing.

Insurers Block Pain-Blocking Devices for Migraine

April 16, 2021

For the 39 million Americans who experience migraine headaches, noninvasive devices offer a new option for stopping painful symptoms. Insurers, however, are giving the devices the cold shoulder.

Insurers Save Costs at Cost of Skin Patients

April 13, 2021

Everyone, it seemed, was willing to help patients access medication without delay when COVID-19 took hold last year.

When Prescribing is Personal

April 8, 2021

Prescribing became more personalized during the pandemic, a new survey of health care providers suggests.

Will the Biden Administration Tackle Co-Pay Card Reform?

April 6, 2021

The Biden administration’s ambitious plan to protect patients is off to a promising start.

A Path to Hepatitis C Elimination for Policymakers

November 2020

Fast Facts: Center for Medicare and Medicaid Innovation

October 2020

Precision Medicine: Redefining Care for Rheumatoid Arthritis

September 2020

Tweets by Alliance for Patient Access

Seventh Annual Summit on Balanced Pain Management

April 2021

National Policy & Advocacy Summit on Biologics

December 2020